HIV salvage regimens can safely omit NRTIs, says US study
Drug resistance acquired during HIV PrEP rapidly disappears after medication is discontinued
No transmission of integrase inhibitor-resistant HIV seen in California patients
Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy
Transmitted HIV drug resistance is persistent but is not harming treatment responses in the UK
High treatment failure rate among Thai children switching to second-line ART
What are the barriers that could stop HIV treatment becoming HIV prevention?
Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy
